Nucleic Acid News and Research

RSS

PrimeraDx gets FDA clearance for ICEPlex C. difficile Assay Kit and ICEPlex System

PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex C. difficile Assay Kit and the ICEPlex System have received 510(k) clearance from the United States Food and Drug Administration.

3 Dec 2013

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Bruker Corporation today announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens.

26 Nov 2013

Seed grants support cancer diagnosis and treatment, vascular health research

Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).

26 Nov 2013

Cleveland Clinic researchers elected as AAAS Fellows for excellent contributions to science

Cleveland Clinic researchers Richard A. Padgett, Ph.D., and Edward F. Plow, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS). This year's AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on Nov. 29, 2013.

26 Nov 2013

MO BIO Laboratories announces launch of PowerClean Pro DNA and RNA Clean-Up Kits

MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the PowerClean Pro DNA and RNA Clean-Up Kits, featuring a fast, 7 minute protocol for removal of amplification inhibitors including humic substances, polysaccharides, polyphenolics, heme, and lipids from purified DNA or RNA.

20 Nov 2013

New 4th generation HIV assays now available to improve screening for HIV infection

Laboratory Corporation of America Holdings announced today the availability of a 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection.

6 Nov 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

MO BIO Laboratories introduces UltraClean-htp 96 Well Swab DNA Kit

MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the UltraClean-htp 96 Well Swab DNA Kit. The kit is designed for rapid mechanical lysis of microbial cells from low biomass and low inhibitor containing swabs, paper or filter paper for direct application to PCR for metagenomic analysis.

2 Oct 2013

Enzymatics Acquires Archerdx For Up To $50M

...

6 Sep 2013

New method to detect genetic variations that initiate colon cancer

A new, highly sensitive method to detect genetic variations that initiate colon cancer could be readily used for noninvasive colon cancer screening, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

4 Sep 2013

Nanostructures made of DNA strands can encapsulate, release small-molecule drugs

Nanoscale "cages" made from strands of DNA can encapsulate small-molecule drugs and release them in response to a specific stimulus, McGill University researchers report in a new study.

2 Sep 2013

Researchers discover role played by epigenetic factors in senescence and age-related diseases

One way cells promote tumor suppression is through a process called senescence, an irreversible arrest of proliferation. Senescence is thought to be associated with normal aging, but is also a protective measure by the body against run-away cell replication.

31 Aug 2013

Novel machine learning-based approach used to predict hepatotoxic potential of DNA drug

New classes of therapeutic antisense oligonucleotides can have toxic effects on the liver. A novel machine learning-based approach used to predict the hepatotoxic potential of an antisense drug based on its chemical sequence is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

28 Aug 2013

Scientists prove 50-year-old hypothesis of RNA 'higher-order' structure

When Francis Crick and James Watson discovered the double helical structure of deoxyribonucleic acid (DNA) in 1953, it began a genetic revolution to map, study, and sequence the building blocks of living organisms.

27 Aug 2013

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

...

22 Aug 2013

Novel potential biomarker present in CSF reveals signs of dementia decade before

A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present in cerebral spinal fluid (CSF) at least a decade before signs of dementia manifest.

16 Aug 2013

Learning "grammar" helps determine whether gene gets switched on or not

Researchers have probed deep into the cell's genome, beyond the basic genetic code, to begin learning the "grammar" that helps determine whether or not a gene gets switched on to make the protein it encodes.

13 Aug 2013

GE, UW scientists to develop new medical device for detecting infectious disease

You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.

9 Aug 2013

New England Biolabs Gains Access To Advanced NGS Library Prep Method

...

From New England Biolabs 6 Aug 2013

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout the body.

29 Jul 2013

Nucleic Acid News and Research

PrimeraDx gets FDA clearance for ICEPlex C. difficile Assay Kit and ICEPlex System

Bruker receives FDA clearance to market MALDI Biotyper CA System in the U.S.

Seed grants support cancer diagnosis and treatment, vascular health research

Cleveland Clinic researchers elected as AAAS Fellows for excellent contributions to science

MO BIO Laboratories announces launch of PowerClean Pro DNA and RNA Clean-Up Kits

New 4th generation HIV assays now available to improve screening for HIV infection

New type of antibiotic kills multidrug-resistant germ common to health care settings

MO BIO Laboratories introduces UltraClean-htp 96 Well Swab DNA Kit

Enzymatics Acquires Archerdx For Up To $50M

New method to detect genetic variations that initiate colon cancer

Nanostructures made of DNA strands can encapsulate, release small-molecule drugs

Researchers discover role played by epigenetic factors in senescence and age-related diseases

Novel machine learning-based approach used to predict hepatotoxic potential of DNA drug

Scientists prove 50-year-old hypothesis of RNA 'higher-order' structure

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

Novel potential biomarker present in CSF reveals signs of dementia decade before

Learning "grammar" helps determine whether gene gets switched on or not

GE, UW scientists to develop new medical device for detecting infectious disease

New England Biolabs Gains Access To Advanced NGS Library Prep Method

New method can pinpoint DNA mutations that could help treat cancer, tuberculosis

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®